| Send us a text (https://www.buzzsprout.com/twilio/text_messages/910414/open_sms) What if the most valuable drug candidates aren’t found but designed on demand? We follow a chemist’s journey from a pencil-and-paper notebook to generative algorithms that propose novel, IP-free molecules tailored to specific targets, and we open the door to how Swiss pharma is rebuilding discovery around AI. To read more about this topic (https://www.swissinfo.ch/eng/multinational-companies/big-pharma-steps-up-race-for-ai-discovered-drugs/79014204) and for more science stories (https://www.swissinfo.ch/eng/research-frontiers/) , visit our website swisinfo.ch (https://www.swissinfo.ch/eng/health-systems/switzerland-charts-new-course-on-gender-medicine-despite-headwinds/90213951) . You can help other people to find our podcast by leaving us a five-star review. Journalist: Jessica Davis Plüss (https://www.swissinfo.ch/eng/healthcare-innovation/longevity-clinics-modern-day-snake-oil-or-the-key-to-healthy-ageing/89101132) Host: Jo Fahy (https://www.swissinfo.ch/eng/author/jo-fahy/) Audio editor/video journalist: Michele Andina (https://www.swissinfo.ch/eng/author/michele-andina/) Distribution and Marketing: Xin Zhang (https://www.linkedin.com/in/xin-zhang-70327481/) SWI swissinfo.ch (https://www.swissinfo.ch/eng/) is a public service media company based in Bern, Switzerland. |
You Might Also Like
Radical-Liberals back Switzerland-EU accords
2025-10-18
The Swiss Radical-Liberal Party is in principle in favour of the new package of agreements negotiated by the European Union and Switzerland. Party delegates in Bern voted 330-104 to support the packages. Nine delegates abstained from voting. +Get the most important news from Switzerland in your inbox Before the vote, supporters and opponents of the …
Patent battle in India tests Roche’s grip on rare disease market
2025-10-16
An Indian court has cleared the way for low-cost alternatives to Roche’s drug Evrysdi for spinal muscular atrophy. What’s behind the decision and what could it mean for rare disease patients everywhere? On October 9 the Delhi High Court refused to issue Roche an injunction to prevent generic manufacturers from making and selling a low-cost …
ABB to power new AI data centres with Nvidia
2025-10-14
Swiss technology group ABB will collaborate with US computer chip manufacturer Nvidia to jointly develop new power supply solutions for future data centres. + Get the most important news from Switzerland in your inbox The partnership will focus on the development and deployment of “state-of-the-art power supply solutions”, ABB announced. These are required for a “highly efficient, scalable power supply for future AI workloads”.
Swiss Post temporarily stops sending goods to the US
2025-08-25
As of Tuesday, Swiss Post will temporarily stop sending postal consignments to the US. This is due to new customs regulations from the US government. However, it will still be possible to send documents and express items to the USA. + Get the most important news from Switzerland in your inbox The US government has …
Swiss exports to US were growing before stinging tariffs
2025-08-21
Swiss exports to the United States inched up in July, the second straight month of expansion before President Donald Trump unexpectedly slapped a 39% tariff on the country. +Get the most important news from Switzerland in your inbox Foreign sales to the US, adjusted for seasonal swings, rose 1.1% from June, the Swiss Office for …
How US tariffs could disrupt the generic drugs supply chain
2025-07-01
Generic drugs run on thin margins and tight supply chains. Any disruption triggered by increased tariffs could raise prices, push some manufacturers out of the market and even worsen medicine shortages. Generic medicines – cheaper versions of branded drugs whose patents have expired – are the backbone of modern healthcare. They account for most prescriptions …
Swiss steel traders face price fixing probe
2025-06-26
The Swiss Federal Competition Commission (ComCo) has opened an investigation into four steel traders accused of illegal collusion.
Swiss Political Cartoonist Patrick Chappatte: Cartoons and the fight for press freedom
2025-06-17
Patrick Chappatte is one of the world’s most prolific cartoonists, with his work being translated into numerous languages and published in 130 countries. Living in the Swiss city of Geneva – home to the UN and a major political hub – he comments on world events with his cartoons.
We talked to Chappatte about the current state of satire, media and free speech in the world. And we looked over his shoulder while he was creating a cartoon for the American outlet The Boston Globe.
Read the full article here: https://www.swissinfo.ch/eng/swiss-position/patrick-chappatte-the-path-for-satire-has-been-getting-narrower/89532782
Reportage by: Giannis Mavris, Carlo Pisani and Céline Stegmüller
—
Swissinfo is the international branch of the Swiss Broadcasting Corporation (SBC). Its role is to
Tags: Featured
2 pings